J. E. Graves

Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib.

M. Heffernan, A. Lind, J. E. Graves, 2006, Journal of the American Academy of Dermatology.

Off-label uses of biologic agents in dermatology: a 2006 update.

D. I. Smith, M. Heffernan, J. E. Graves, 2006, Seminars in cutaneous medicine and surgery.

Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine.

M. Phillips, J. Nunley, J. E. Graves, 2005, Journal of the American Academy of Dermatology.

Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2).

M. Heffernan, J. E. Graves, Kara S Nunley, 2007, Journal of the American Academy of Dermatology.

Endoscopic cauterization for treatment of fourth branchial cleft sinuses.

S. Manning, J. McClay, M. Biavati, 1998, Archives of otolaryngology--head & neck surgery.

Skin cancer examination teaching in US medical education.

Donald R. Miller, B. Gilchrest, A. Geller, 2006, Archives of dermatology.

A single-center, open-label, prospective pilot study of subcutaneous efalizumab for oral erosive lichen planus.

M. Tabacchi, M. Heffernan, D. Bentley, 2007, Journal of drugs in dermatology : JDD.

Efalizumab-induced subacute cutaneous lupus erythematosus.

M. Heffernan, D. Bentley, J. E. Graves, 2006, Journal of the American Academy of Dermatology.